134 related articles for article (PubMed ID: 12394396)
1. The role of nursing in managing treatment-associated adverse effects in patients with hepatitis C.
Leone NE
Gastroenterol Nurs; 2002; 25(5):201-3. PubMed ID: 12394396
[TBL] [Abstract][Full Text] [Related]
2. [The adherence in the treatment of chronic hepatitis C].
Pawłowska M; Halota W
Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hepatitis C: therapeutic management].
Bourliere M
Gastroenterol Clin Biol; 2008 May; 32(5 Pt 2):S166-71. PubMed ID: 18482813
[No Abstract] [Full Text] [Related]
4. The role of physician extenders in managing patients with chronic hepatitis C.
Gujral H; Viscomi C; Collantes R
Cleve Clin J Med; 2004 May; 71 Suppl 3():S33-7. PubMed ID: 15468616
[TBL] [Abstract][Full Text] [Related]
5. Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function.
Georgiopoulos G; Alexopoulou A; Pouriki S; Vasilieva L; Laina A; Bampatsias D; Mani I; Kontogiannis C; Tousoulis D; Stamatelopoulos K; Dourakis SP
Hellenic J Cardiol; 2019; 60(2):143-145. PubMed ID: 31146885
[No Abstract] [Full Text] [Related]
6. Current treatment for chronic hepatitis C.
Davis GL
Rev Gastroenterol Disord; 2001; 1(2):59-72. PubMed ID: 12120176
[TBL] [Abstract][Full Text] [Related]
7. [Quality of life of patients with chronic hepatitis C: effect of treatments].
Couzigou P
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B257-63. PubMed ID: 12180299
[No Abstract] [Full Text] [Related]
8. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
Sidhu-Malik NK; Kaplan AL
J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
[TBL] [Abstract][Full Text] [Related]
9. [Ribavirin].
Taéron C
Rev Infirm; 2009; (152):47-9. PubMed ID: 19702029
[No Abstract] [Full Text] [Related]
10. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
Mauss S
J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
[TBL] [Abstract][Full Text] [Related]
11. Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia.
Ong JP; Younossi ZM
Cleve Clin J Med; 2004 May; 71 Suppl 3():S17-21. PubMed ID: 15468613
[TBL] [Abstract][Full Text] [Related]
12. Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
Marcellin F; Protopopescu C; Poizot-Martin I; Miailhes P; Esterle L; Wittkop L; Spire B; Bocquier A; Salmon-Ceron D; Dabis F; Carrieri MP;
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1003-7. PubMed ID: 27177169
[TBL] [Abstract][Full Text] [Related]
13. Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?
Blacklaws H; Gardner A; Usher K
J Clin Nurs; 2011 May; 20(9-10):1215-24. PubMed ID: 21371144
[TBL] [Abstract][Full Text] [Related]
14. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
[TBL] [Abstract][Full Text] [Related]
15. [Side effects of interferon therapy for chronic hepatitis C].
Arase Y
Nihon Rinsho; 2006 Jul; 64(7):1363-7. PubMed ID: 16838657
[TBL] [Abstract][Full Text] [Related]
16. Chronic cough associated with interferon/ribavirin therapy for hepatitis C.
Dicpinigaitis PV; Weiner FR
J Clin Pharm Ther; 2011 Jun; 36(3):416-8. PubMed ID: 21545621
[TBL] [Abstract][Full Text] [Related]
17. [Lingual hyperpigmentation in a patient with chronic infection].
López Peláez MV; González Díaz P; Téllez Molina MJ; Vergas García J
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):264-5. PubMed ID: 23260387
[No Abstract] [Full Text] [Related]
18. Interferon-induced central retinal vein thrombosis.
Nazir L; Husain A; Haroon W; Shaikh MI; Mirza SA; Khan Z
J Coll Physicians Surg Pak; 2012 Nov; 22(11):735-6. PubMed ID: 23146860
[TBL] [Abstract][Full Text] [Related]
19. Fatal lactic acidosis in a HIV-positive patient treated with interferon and ribavirin for chronic hepatitis C.
Guyader D; Poinsignon Y; Cano Y; Saout L
J Hepatol; 2002 Aug; 37(2):289-91. PubMed ID: 12127440
[No Abstract] [Full Text] [Related]
20. Management of chronic hepatitis C in childhood: the impact of therapy in the clinical practice during the first 2 decades.
Bortolotti F; Indolfi G; Zancan L; Giacchino R; Verucchi G; Cammà C; Barbera C; Resti M; Marazzi MG; Guido M
Dig Liver Dis; 2011 Apr; 43(4):325-9. PubMed ID: 21111693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
